At a glance
- Originator Molecules for Health
- Class Antineoplastics; Benzamidines
- Mechanism of Action Ribonucleoside triphosphate reductase inhibitors; Ribonucleotide reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Cytomegalovirus infections; Hepatitis B; HIV infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cytomegalovirus infections in USA (Parenteral, Injection)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hepatitis-B in USA (Parenteral, Injection)
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in USA (Parenteral, Injection)